BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26703465)

  • 1. β-Arrestin-mediated Angiotensin II Signaling Controls the Activation of ARF6 Protein and Endocytosis in Migration of Vascular Smooth Muscle Cells.
    Charles R; Namkung Y; Cotton M; Laporte SA; Claing A
    J Biol Chem; 2016 Feb; 291(8):3967-81. PubMed ID: 26703465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.
    Kim J; Ahn S; Rajagopal K; Lefkowitz RJ
    J Biol Chem; 2009 May; 284(18):11953-62. PubMed ID: 19254952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GTPase ARF6 Controls ROS Production to Mediate Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation.
    Bourmoum M; Charles R; Claing A
    PLoS One; 2016; 11(1):e0148097. PubMed ID: 26824355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods to Investigate the β-Arrestin-Mediated Control of ARF6 Activation to Regulate Trafficking and Actin Cytoskeleton Remodeling.
    Charles R; Bourmoum M; Campbell S; Claing A
    Methods Mol Biol; 2019; 1957():159-168. PubMed ID: 30919353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II activates NF-κB through AT1A receptor recruitment of β-arrestin in cultured rat vascular smooth muscle cells.
    Morinelli TA; Lee MH; Kendall RT; Luttrell LM; Walker LP; Ullian ME
    Am J Physiol Cell Physiol; 2013 Jun; 304(12):C1176-86. PubMed ID: 23576578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis.
    Claing A; Chen W; Miller WE; Vitale N; Moss J; Premont RT; Lefkowitz RJ
    J Biol Chem; 2001 Nov; 276(45):42509-13. PubMed ID: 11533043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
    Tang W; Strachan RT; Lefkowitz RJ; Rockman HA
    J Biol Chem; 2014 Oct; 289(41):28271-83. PubMed ID: 25170081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Src regulates clathrin adapter protein 2 interaction with beta-arrestin and the angiotensin II type 1 receptor during clathrin- mediated internalization.
    Fessart D; Simaan M; Laporte SA
    Mol Endocrinol; 2005 Feb; 19(2):491-503. PubMed ID: 15498833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. {beta}-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation.
    Ahn S; Kim J; Hara MR; Ren XR; Lefkowitz RJ
    J Biol Chem; 2009 Mar; 284(13):8855-65. PubMed ID: 19171933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the GTPase ARF6 regulates invasion of human vascular smooth muscle cells by stimulating MMP14 activity.
    Fiola-Masson E; Artigalas J; Campbell S; Claing A
    Sci Rep; 2022 Jun; 12(1):9532. PubMed ID: 35680971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ADP ribosylation factor nucleotide exchange factor ARNO promotes beta-arrestin release necessary for luteinizing hormone/choriogonadotropin receptor desensitization.
    Mukherjee S; Gurevich VV; Jones JC; Casanova JE; Frank SR; Maizels ET; Bader MF; Kahn RA; Palczewski K; Aktories K; Hunzicker-Dunn M
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5901-6. PubMed ID: 10811902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrestin-dependent angiotensin AT1 receptor signaling regulates Akt and mTor-mediated protein synthesis.
    Kendall RT; Lee MH; Pleasant DL; Robinson K; Kuppuswamy D; McDermott PJ; Luttrell LM
    J Biol Chem; 2014 Sep; 289(38):26155-26166. PubMed ID: 25081544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway.
    Yang X; Zhu MJ; Sreejayan N; Ren J; Du M
    Mol Cells; 2005 Oct; 20(2):263-70. PubMed ID: 16267402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The calcium-sensing receptor changes cell shape via a beta-arrestin-1 ARNO ARF6 ELMO protein network.
    Bouschet T; Martin S; Kanamarlapudi V; Mundell S; Henley JM
    J Cell Sci; 2007 Aug; 120(Pt 15):2489-97. PubMed ID: 17623778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrestins 2 and 3 differentially regulate ETA and P2Y2 receptor-mediated cell signaling and migration in arterial smooth muscle.
    Morris GE; Nelson CP; Brighton PJ; Standen NB; Challiss RA; Willets JM
    Am J Physiol Cell Physiol; 2012 Mar; 302(5):C723-34. PubMed ID: 22159081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs.
    Zimmerman B; Beautrait A; Aguila B; Charles R; Escher E; Claing A; Bouvier M; Laporte SA
    Sci Signal; 2012 Apr; 5(221):ra33. PubMed ID: 22534132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription.
    Lee MH; El-Shewy HM; Luttrell DK; Luttrell LM
    J Biol Chem; 2008 Jan; 283(4):2088-97. PubMed ID: 18006496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arf6 negatively controls the rapid recycling of the β2 adrenergic receptor.
    Macia E; Partisani M; Paleotti O; Luton F; Franco M
    J Cell Sci; 2012 Sep; 125(Pt 17):4026-35. PubMed ID: 22611259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor-induced clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation.
    McLaughlin NJ; Banerjee A; Kelher MR; Gamboni-Robertson F; Hamiel C; Sheppard FR; Moore EE; Silliman CC
    J Immunol; 2006 Jun; 176(11):7039-50. PubMed ID: 16709866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3.
    McDonald PH; Chow CW; Miller WE; Laporte SA; Field ME; Lin FT; Davis RJ; Lefkowitz RJ
    Science; 2000 Nov; 290(5496):1574-7. PubMed ID: 11090355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.